Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Acceleron Pharma Inc

+ Add to Watchlist

XLRN:US

34.6200 USD 1.2300 3.68%

As of 20:10:00 ET on 05/27/2015.

Snapshot for Acceleron Pharma Inc (XLRN)

Open: 33.6300 Day's Range: 33.1000 - 35.0000 Volume: 188,939
Previous Close: 33.3900 52wk Range: 23.6100 - 48.5000 1-Yr Rtn: +11.68%

Stock Chart for XLRN

No chart data available.
  • XLRN:US 34.6200
  • 1D
  • 1M
  • 1Y
33.3900
Interactive XLRN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XLRN

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.6715
Est. EPS (USD) (12/2015) -1.3070
Est. PEG Ratio -
Market Cap (M USD) 1,135.95
Shares Outstanding (M) 32.81
30 Day Average Volume 195,442
Price/Book (mrq) 7.7801
Price/Sale (ttm) 70.5666
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XLRN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XLRN

Acceleron Pharma, Inc. provides pharmaceutical products. The Company focuses on discovering, developing, manufacturing, and marketing of protein therapeutics for cancer and orphan diseases. Acceleron Pharma serves patients throughout the United States.

John L KnopfPresident/CEO/Co-FounderSteven ErtelExec VP/COO
Matthew L ShermanExec VP/Chief Medical OfficerKevin F McLaughlinSenior VP/CFO/Treasurer
More Company Profile & Key Executives for XLRN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil